Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.53% · OPTIONAL
· Ophthalmic Goods
RESEARCH SNAPSHOTSTAAR SURGICAL CO's latest supported as-filed period reports revenue of $93.5M; gross margin moved 54 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.53% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 21.05% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 111.04% · CORE
Level · gp.fundamentals.gross_margin
Raw value 74.55% · CORE
Level · gp.fundamentals.operating_margin
Raw value 10.80% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 10.63% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -11.1% from the comparable as-filed period.
Gross margin changed +54 basis points from the comparable as-filed period.
Gross profit changed +112.6% from the comparable as-filed period.
Net income changed +147.9% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
STAA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001325697-26-000011SEC ↗4Aug 18, 2026Period Aug 14, 20260001970778-26-000014SEC ↗4Aug 18, 2026Period Aug 14, 20260001731487-26-000011SEC ↗10-QAug 12, 2026Period Jul 3, 20260000718937-26-000037SEC ↗8-KAug 12, 2026Period Aug 12, 20260000718937-26-000036SEC ↗8-KAug 6, 2026Period Aug 5, 20260001193125-26-337197SEC ↗4Aug 4, 2026Period Jul 31, 20260001970778-26-000012SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Option ExerciseDirect | 7,331 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Tax WithholdingDirect | 3,730 | $26 | $97,651 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Option ExerciseDirect | 3,666 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Tax WithholdingDirect | 1,865 | $26 | $48,826 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 7.01% · OPTIONAL
Operating income changed +133.7% from the comparable as-filed period.
Operating margin changed +7841 basis points from the comparable as-filed period.
Research & development changed -3.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-07-03. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001325697-26-000009| Grant Or AwardDirect |
| 22,493 |
| $0 |
| $0 |
| Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Grant Or AwardDirect | 40,471 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Grant Or AwardDirect | 37,962 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Grant Or AwardDirect | 131,830 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Grant Or AwardDirect | 123,659 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Option ExerciseDirect | 7,331 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | Foust WarrenPresident and CEO | Option ExerciseDirect | 3,666 | $0 | $0 | Form 4 ↗ |